PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2023
Total Assets: $60.3K
Liabilities Breakdown FY2023
Total Liabilities: $3.2M
Asset Breakdown
Total Assets: $60.3K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $302 | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $60.0K | 99.5% |
Liabilities Breakdown
Total Liabilities: $3.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $966.7K | 30.4% |
| Long-Term Debt | $390.5K | 12.3% |
| Other Liabilities | $1.8M | 57.3% |